Status:
NOT_YET_RECRUITING
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Naevi
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The background to this research is that frequent medical screening of the general population for melanoma is not feasible. The real challenge of this project is to develop an automatic process for det...
Eligibility Criteria
Inclusion
- Male or female aged 18 and over
- Patient with more than 15 nevi (moles) of various phototypes (I to III)
- Patient who has received information about the study and has not expressed any opposition
- Patient who is a beneficiary or entitled person under a social security scheme
Exclusion
- Patients with phototype V
- Patients with chronic inflammatory skin diseases
- Claustrophobic patients
- Patients who are bedridden or handicapped
- Patients who are excluded from another research protocol at the time of collection of the non-objection.
- Patients covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women),
- Any other reason which, in the investigator's opinion, could interfere with the evaluation of the research objectives.
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06999499
Start Date
March 1 2026
End Date
June 1 2028
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Conception
Marseille, France, 13005